<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Prospective Grant of Exclusive License: Pre-Clinical Evaluation and Commercial Development of Human Therapeutics for Liver Cancer and Ovarian Cancer Within the Scope of the Licensed Patent Rights</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Prospective Grant of Exclusive License: Pre-Clinical Evaluation and Commercial Development of Human Therapeutics for Liver Cancer and Ovarian Cancer Within the Scope of the Licensed Patent Rights</h1>
    <p class="timestamp">Published: 2014-02-18 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>This is notice, in accordance with 35 U.S.C. 209 and 37 CFR part 404, that the National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an exclusive evaluation option license to practice the inventions covered under the scope of the following patents and patent applications: <bullet> United States Patent No. 8,207,142 issued Jun 26, 2012 entitled "Inhibitor of DNA Methylation" (HHS Ref. No. E-081-2001/2- US-06); <bullet> EP Patent No. 1418949 issued J...</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, National Institutes of Health</p>
    <p><strong>Document Number:</strong> 2014-03410</p>
    <p><strong>Publication Date:</strong> 2014-02-18</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2014/02/18/2014-03410/prospective-grant-of-exclusive-license-pre-clinical-evaluation-and-commercial-development-of-human">https://www.federalregister.gov/documents/2014/02/18/2014-03410/prospective-grant-of-exclusive-license-pre-clinical-evaluation-and-commercial-development-of-human</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2014-03410</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
